In GBM, cells have a high demand for iron to promote tumor growth and progression, so these cells are susceptible to ferroptosis, of which SLC7A11 (solute carrier family 7 member 11) is a key antagonist [585]. The gene discussed is SLC7A11; the disease is neoplasm.